Why the study?
Short- and long-term procedural outcomes for future pregnancies in women of childbearing age who have received prior TAVR or TAVR in SAVR are unknown.
Repeat pregnancy in a patient with prior TAVR in SAVR can result in favorable maternal and fetal outcomes, but carries a risk of third-trimester cardiac complications, necessitating multidisciplinary team management.
Answers are grounded in this paper and cite their sources.
Initial report of repeat pregnancy after TAVR-in-SAVR supports feasibility; leaves open safety and management questions for women of childbearing age.
Transcatheter aortic valve replacement (TAVR) within a severely stenotic native aortic valve or previously placed surgical biologic aortic valve replacement (SAVR) is a rare occurrence in pregnant patients. The short- and long-term procedural outcomes for future pregnancies in these women or any woman of child bearing age who have received prior TAVR or TAVR in SAVR, are unknown. We describe the first result of a repeat pregnancy outcome in a woman with a history of prior TAVR in SAVR. Both maternal and fetal outcomes were favorable, but maternal cardiac complications observed in the third trimester emphasize our concerns regarding risk for cardiac complications in subsequent pregnancies in patients with a prior TAVR in SAVR. Despite the maternal complications that occurred during repeat pregnancy in this patient, a successful pregnancy outcome reaffirms our recommendation to utilize a multidisciplinary team for pregnancy management in patients with prior TAVR or TAVR in SAVR and to help in the management of any cardiac complications that may occur during or shortly after pregnancy.
No takes yet. Share an insight, caveat, or question.
Rasmussen et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: